Author: Brittney Wheeler

Researchers at WashU Medicine described, in mice, a brain pathway that connects the loss of motivation characteristic of advanced cancer to cancer-related inflammation and identified opportunities to block this pathway and restore motivation.

WashU Medicine’s Eric C. Leuthardt, MD, and Robi Mitra, PhD, have been named fellows of the American Institute for Medical and Biological Engineering.

Megan Tierney Baldridge, MD, PhD, an associate professor in the Department of Medicine at WashU Medicine, received a $100,000 grant to explore the interactions between the viruses that infect bacteria, known as bacteriophages, and human intestinal epithelial cells.

Researchers at WashU Medicine found that a small population of immune cells in the mouse intestine prevents allergic responses to food, suggesting that targeting such cells therapeutically could potentially lead to a new treatment for allergies.

Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an inflammatory illness precisely when it was most needed.

A clinical trial led by Richard S. Hotchkiss, MD, a professor of anesthesiology at WashU Medicine, has found that treating critically ill COVID-19 patients with an immune-boosting protein reduces life-threatening secondary infections, a major cause of death in such patients.

A blood test for Alzheimer’s disease developed by researchers at WashU Medicine and Lund University not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed.

The National Institutes of Health (NIH) is supporting a WashU Medicine effort to track neuroinflammation in the brains of patients with Parkinson’s disease.

Researchers at WashU Medicine have found a way to target the vessels that drain waste from the brain. Rejuvenating those vessels could open the door to new therapies to prevent cognitive decline.

The Jansky/Bander Family Fund, a generous commitment of $1.1 million over five years, has been established to advance critical initiatives within the Section of Movement Disorders in the Department of Neurology at WashU Medicine.